Cambodia

Cambodia

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
6.55 (5.50 - 7.56) 2019 Modelled IHME
6.56 (5.51 - 7.56) 2018 Modelled IHME
6.6 (5.46 - 7.71) 2017 Modelled IHME
6.93 (5.73 - 8.05) 2016 Modelled IHME
7.37 (6.08 - 8.64) 2015 Modelled IHME
7.6 (6.30 - 8.83) 2014 Modelled IHME
7.79 (6.45 - 9.01) 2013 Modelled IHME
7.95 (6.62 - 9.17) 2012 Modelled IHME
8.11 (6.75 - 9.39) 2011 Modelled IHME
8.27 (6.89 - 9.62) 2010 Modelled IHME
8.46 (7.02 - 9.79) 2009 Modelled IHME
8.67 (7.15 - 10) 2008 Modelled IHME
8.87 (7.25 - 10.25) 2007 Modelled IHME
9.05 (7.31 - 10.48) 2006 Modelled IHME
9.18 (7.37 - 10.71) 2005 Modelled IHME
9.28 (7.52 - 10.76) 2004 Modelled IHME
9.37 (7.70 - 10.82) 2003 Modelled IHME
9.45 (7.86 - 10.87) 2002 Modelled IHME
9.52 (7.93 - 10.94) 2001 Modelled IHME
9.58 (8 - 11.13) 2000 Modelled IHME
9.65 (8.04 - 11.19) 1999 Modelled IHME
9.74 (8.05 - 11.34) 1998 Modelled IHME
9.82 (8.03 - 11.45) 1997 Modelled IHME
9.88 (7.99 - 11.54) 1996 Modelled IHME
9.9 (7.95 - 11.62) 1995 Modelled IHME
9.89 (7.96 - 11.66) 1994 Modelled IHME
9.87 (7.97 - 11.68) 1993 Modelled IHME
9.84 (7.97 - 11.70) 1992 Modelled IHME
9.78 (7.93 - 11.75) 1991 Modelled IHME
9.7 (7.90 - 11.77) 1990 Modelled IHME
2.98 (2.23 - 4) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.55 (0.40 - 0.72) 2019 Modelled IHME
0.56 (0.42 - 0.74) 2018 Modelled IHME
0.59 (0.44 - 0.77) 2017 Modelled IHME
0.64 (0.47 - 0.85) 2016 Modelled IHME
0.7 (0.50 - 0.95) 2015 Modelled IHME
0.75 (0.54 - 1) 2014 Modelled IHME
0.8 (0.57 - 1.07) 2013 Modelled IHME
0.84 (0.62 - 1.12) 2012 Modelled IHME
0.89 (0.65 - 1.19) 2011 Modelled IHME
0.95 (0.69 - 1.27) 2010 Modelled IHME
1.02 (0.74 - 1.36) 2009 Modelled IHME
1.09 (0.78 - 1.45) 2008 Modelled IHME
1.17 (0.84 - 1.56) 2007 Modelled IHME
1.29 (0.92 - 1.70) 2006 Modelled IHME
1.44 (1.03 - 1.91) 2005 Modelled IHME
2 (1.47 - 2.61) 2004 Modelled IHME
3.1 (2.33 - 3.99) 2003 Modelled IHME
4.36 (3.33 - 5.57) 2002 Modelled IHME
5.44 (4.15 - 6.96) 2001 Modelled IHME
5.97 (4.53 - 7.70) 2000 Modelled IHME
6.11 (4.60 - 7.96) 1999 Modelled IHME
6.22 (4.64 - 8.09) 1998 Modelled IHME
6.3 (4.63 - 8.28) 1997 Modelled IHME
6.36 (4.64 - 8.43) 1996 Modelled IHME
6.38 (4.63 - 8.55) 1995 Modelled IHME
6.37 (4.66 - 8.47) 1994 Modelled IHME
6.36 (4.66 - 8.50) 1993 Modelled IHME
6.33 (4.66 - 8.37) 1992 Modelled IHME
6.28 (4.68 - 8.32) 1991 Modelled IHME
6.21 (4.63 - 8.13) 1990 Modelled IHME
0.6 2017 Survey/reported WHO WPRO, Woodring J et al, 2017
0.56 (0.37 - 0.79) 2015 Modelled WHO
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
14.7 (10.70 - 19.70) 2019 Modelled IHME
14.8 (10.80 - 19.70) 2018 Modelled IHME
14.8 (10.90 - 19.70) 2017 Modelled IHME
14.7 (10.90 - 19.40) 2016 Modelled IHME
14.7 (11 - 19.40) 2015 Modelled IHME
15.3 (11.50 - 19.80) 2014 Modelled IHME
16.6 (12.70 - 21.20) 2013 Modelled IHME
18 (14 - 22.70) 2012 Modelled IHME
19.1 (15 - 23.70) 2011 Modelled IHME
19.6 (15.50 - 24.20) 2010 Modelled IHME
19.6 (15.50 - 24.30) 2009 Modelled IHME
19.4 (15.30 - 24.10) 2008 Modelled IHME
19.3 (15.20 - 24) 2007 Modelled IHME
19.1 (14.90 - 23.70) 2006 Modelled IHME
19 (14.80 - 23.50) 2005 Modelled IHME
18.8 (14.70 - 23.30) 2004 Modelled IHME
18.6 (14.60 - 23.20) 2003 Modelled IHME
18.5 (14.50 - 23) 2002 Modelled IHME
18.4 (14.40 - 22.90) 2001 Modelled IHME
18.3 (14.40 - 22.60) 2000 Modelled IHME
18.3 (14.30 - 22.50) 1999 Modelled IHME
18.2 (14.40 - 22.40) 1998 Modelled IHME
18.1 (14.40 - 22.40) 1997 Modelled IHME
18.1 (14.30 - 22.50) 1996 Modelled IHME
18.1 (14.40 - 22.40) 1995 Modelled IHME
18 (14.10 - 22.50) 1994 Modelled IHME
17.8 (14 - 22.40) 1993 Modelled IHME
17.8 (13.90 - 22.20) 1992 Modelled IHME
17.9 (14 - 22.20) 1991 Modelled IHME
18 (13.80 - 22.43) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
2,446 (1,770 - 3,267) 2019 Modelled IHME
2,419 (1,771 - 3,228) 2018 Modelled IHME
2,389 (1,761 - 3,186) 2017 Modelled IHME
2,334 (1,732 - 3,080) 2016 Modelled IHME
2,301 (1,716 - 3,028) 2015 Modelled IHME
2,360 (1,779 - 3,059) 2014 Modelled IHME
2,517 (1,934 - 3,224) 2013 Modelled IHME
2,692 (2,091 - 3,398) 2012 Modelled IHME
2,814 (2,211 - 3,493) 2011 Modelled IHME
2,845 (2,252 - 3,523) 2010 Modelled IHME
2,803 (2,222 - 3,481) 2009 Modelled IHME
2,745 (2,164 - 3,404) 2008 Modelled IHME
2,688 (2,112 - 3,339) 2007 Modelled IHME
2,619 (2,045 - 3,255) 2006 Modelled IHME
2,573 (2,001 - 3,185) 2005 Modelled IHME
2,514 (1,959 - 3,110) 2004 Modelled IHME
2,454 (1,920 - 3,060) 2003 Modelled IHME
2,403 (1,879 - 2,989) 2002 Modelled IHME
2,348 (1,845 - 2,926) 2001 Modelled IHME
2,302 (1,811 - 2,845) 2000 Modelled IHME
2,265 (1,777 - 2,793) 1999 Modelled IHME
2,223 (1,754 - 2,727) 1998 Modelled IHME
2,171 (1,721 - 2,686) 1997 Modelled IHME
2,130 (1,686 - 2,641) 1996 Modelled IHME
2,089 (1,658 - 2,587) 1995 Modelled IHME
2,039 (1,606 - 2,551) 1994 Modelled IHME
1,988 (1,560 - 2,496) 1993 Modelled IHME
1,940 (1,520 - 2,421) 1992 Modelled IHME
1,901 (1,489 - 2,357) 1991 Modelled IHME
1,868 (1,436 - 2,327) 1990 Modelled IHME
3,920 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
33 (26 - 41) 2019 Modelled IHME
33 (26 - 41) 2018 Modelled IHME
33 (26 - 41) 2017 Modelled IHME
33 (26 - 41) 2016 Modelled IHME
33 (26 - 42) 2015 Modelled IHME
34 (27 - 42) 2014 Modelled IHME
35 (27 - 43) 2013 Modelled IHME
35 (28 - 44) 2012 Modelled IHME
36 (28 - 44) 2011 Modelled IHME
36 (29 - 44) 2010 Modelled IHME
36 (29 - 44) 2009 Modelled IHME
36 (29 - 44) 2008 Modelled IHME
36 (29 - 45) 2007 Modelled IHME
36 (29 - 44) 2006 Modelled IHME
36 (29 - 45) 2005 Modelled IHME
36 (29 - 44) 2004 Modelled IHME
36 (29 - 44) 2003 Modelled IHME
36 (29 - 44) 2002 Modelled IHME
36 (28 - 44) 2001 Modelled IHME
36 (28 - 45) 2000 Modelled IHME
36 (28 - 45) 1999 Modelled IHME
35 (28 - 44) 1998 Modelled IHME
35 (27 - 44) 1997 Modelled IHME
35 (27 - 44) 1996 Modelled IHME
35 (26 - 44) 1995 Modelled IHME
34 (26 - 43) 1994 Modelled IHME
34 (26 - 43) 1993 Modelled IHME
34 (26 - 43) 1992 Modelled IHME
34 (26 - 43) 1991 Modelled IHME
34 (25 - 43) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
73 2018 Survey/reported WHO/UNICEF
79 2017 Survey/reported WHO/UNICEF
87 2016 Survey/reported WHO/UNICEF
88 2015 Survey/reported WHO/UNICEF
91 2014 Survey/reported WHO/UNICEF
62 2013 Survey/reported WHO/UNICEF
68 2012 Survey/reported WHO/UNICEF
68 2011 Survey/reported WHO/UNICEF
56 2010 Survey/reported WHO/UNICEF
52 2009 Survey/reported WHO/UNICEF
43 2008 Survey/reported WHO/UNICEF
22 2007 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
92 2018 Survey/reported WHO/UNICEF
93 2017 Survey/reported WHO/UNICEF
93 2016 Survey/reported WHO/UNICEF
92 2015 Survey/reported WHO/UNICEF
91 2014 Survey/reported WHO/UNICEF
86 2013 Survey/reported WHO/UNICEF
91 2012 Survey/reported WHO/UNICEF
91 2011 Survey/reported WHO/UNICEF
91 2010 Survey/reported WHO/UNICEF
92 2009 Survey/reported WHO/UNICEF
91 2008 Survey/reported WHO/UNICEF
82 2007 Survey/reported WHO/UNICEF
80 2006 Survey/reported WHO/UNICEF
Showing out of
Show more
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Year of birth dose introduction
2003
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
Few (1-10%)

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
5.36 (4.30 - 6.58) 2019 Modelled IHME
5.24 (4.23 - 6.37) 2018 Modelled IHME
5.17 (4.21 - 6.26) 2017 Modelled IHME
5.15 (4.24 - 6.15) 2016 Modelled IHME
5.14 (4.22 - 6.20) 2015 Modelled IHME
5.14 (4.23 - 6.17) 2014 Modelled IHME
5.15 (4.24 - 6.18) 2013 Modelled IHME
5.16 (4.25 - 6.24) 2012 Modelled IHME
5.17 (4.24 - 6.29) 2011 Modelled IHME
5.18 (4.22 - 6.36) 2010 Modelled IHME
5.22 (4.29 - 6.39) 2009 Modelled IHME
5.3 (4.36 - 6.44) 2008 Modelled IHME
5.4 (4.45 - 6.54) 2007 Modelled IHME
5.5 (4.52 - 6.66) 2006 Modelled IHME
5.58 (4.58 - 6.81) 2005 Modelled IHME
5.64 (4.61 - 6.84) 2004 Modelled IHME
5.71 (4.66 - 6.93) 2003 Modelled IHME
5.76 (4.71 - 7.06) 2002 Modelled IHME
5.81 (4.72 - 7.17) 2001 Modelled IHME
5.84 (4.73 - 7.28) 2000 Modelled IHME
5.87 (4.77 - 7.27) 1999 Modelled IHME
5.9 (4.79 - 7.23) 1998 Modelled IHME
5.92 (4.82 - 7.25) 1997 Modelled IHME
5.94 (4.83 - 7.32) 1996 Modelled IHME
5.96 (4.84 - 7.30) 1995 Modelled IHME
5.98 (4.85 - 7.35) 1994 Modelled IHME
6 (4.85 - 7.37) 1993 Modelled IHME
6.03 (4.90 - 7.43) 1992 Modelled IHME
6.05 (4.89 - 7.47) 1991 Modelled IHME
6.07 (4.88 - 7.54) 1990 Modelled IHME
Showing out of
Show more

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
2.3 2011 Survey/reported Akkarathamrongsin S et al, 2011
2.3 (2.30 - 14.70) 2014 Modelled Gower et al, 2014
Showing out of
Show more

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
17.9 (13.10 - 23.60) 2019 Modelled IHME
17.7 (13 - 23.30) 2018 Modelled IHME
17.5 (12.80 - 22.90) 2017 Modelled IHME
17.2 (12.60 - 22.40) 2016 Modelled IHME
17 (12.40 - 22) 2015 Modelled IHME
16.5 (12.30 - 21.10) 2014 Modelled IHME
15.9 (11.90 - 20.30) 2013 Modelled IHME
15.2 (11.70 - 19.50) 2012 Modelled IHME
14.8 (11.50 - 18.90) 2011 Modelled IHME
14.6 (11.40 - 18.70) 2010 Modelled IHME
14.5 (11.30 - 18.50) 2009 Modelled IHME
14.4 (11.20 - 18.30) 2008 Modelled IHME
14.4 (11.10 - 18.20) 2007 Modelled IHME
14.3 (11 - 18) 2006 Modelled IHME
14.3 (11 - 18) 2005 Modelled IHME
14.1 (11 - 17.90) 2004 Modelled IHME
14 (10.90 - 17.60) 2003 Modelled IHME
13.8 (10.80 - 17.60) 2002 Modelled IHME
13.7 (10.60 - 17.20) 2001 Modelled IHME
13.6 (10.50 - 17.20) 2000 Modelled IHME
13.6 (10.50 - 17) 1999 Modelled IHME
13.6 (10.50 - 17) 1998 Modelled IHME
13.6 (10.40 - 16.90) 1997 Modelled IHME
13.6 (10.40 - 17) 1996 Modelled IHME
13.6 (10.40 - 17.10) 1995 Modelled IHME
13.5 (10.30 - 17.10) 1994 Modelled IHME
13.5 (10.30 - 17.10) 1993 Modelled IHME
13.5 (10.30 - 17.10) 1992 Modelled IHME
13.6 (10.30 - 17.40) 1991 Modelled IHME
13.7 (10.40 - 17.70) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
2,976 (2,173 - 3,915) 2019 Modelled IHME
2,906 (2,136 - 3,821) 2018 Modelled IHME
2,833 (2,064 - 3,696) 2017 Modelled IHME
2,736 (1,995 - 3,551) 2016 Modelled IHME
2,654 (1,941 - 3,440) 2015 Modelled IHME
2,544 (1,893 - 3,258) 2014 Modelled IHME
2,410 (1,813 - 3,078) 2013 Modelled IHME
2,282 (1,750 - 2,915) 2012 Modelled IHME
2,178 (1,696 - 2,792) 2011 Modelled IHME
2,117 (1,655 - 2,713) 2010 Modelled IHME
2,075 (1,613 - 2,657) 2009 Modelled IHME
2,037 (1,576 - 2,584) 2008 Modelled IHME
2,003 (1,544 - 2,534) 2007 Modelled IHME
1,962 (1,511 - 2,474) 2006 Modelled IHME
1,932 (1,487 - 2,442) 2005 Modelled IHME
1,888 (1,465 - 2,390) 2004 Modelled IHME
1,838 (1,430 - 2,315) 2003 Modelled IHME
1,795 (1,398 - 2,280) 2002 Modelled IHME
1,751 (1,358 - 2,204) 2001 Modelled IHME
1,716 (1,328 - 2,164) 2000 Modelled IHME
1,689 (1,304 - 2,105) 1999 Modelled IHME
1,659 (1,274 - 2,068) 1998 Modelled IHME
1,624 (1,240 - 2,025) 1997 Modelled IHME
1,597 (1,220 - 1,997) 1996 Modelled IHME
1,569 (1,204 - 1,973) 1995 Modelled IHME
1,535 (1,174 - 1,944) 1994 Modelled IHME
1,500 (1,151 - 1,909) 1993 Modelled IHME
1,468 (1,125 - 1,866) 1992 Modelled IHME
1,442 (1,098 - 1,850) 1991 Modelled IHME
1,421 (1,074 - 1,839) 1990 Modelled IHME
944 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
35 (27 - 44) 2019 Modelled IHME
35 (27 - 44) 2018 Modelled IHME
35 (27 - 43) 2017 Modelled IHME
35 (26 - 43) 2016 Modelled IHME
34 (26 - 42) 2015 Modelled IHME
34 (26 - 42) 2014 Modelled IHME
34 (26 - 42) 2013 Modelled IHME
33 (25 - 41) 2012 Modelled IHME
33 (25 - 41) 2011 Modelled IHME
32 (25 - 40) 2010 Modelled IHME
32 (25 - 40) 2009 Modelled IHME
32 (24 - 39) 2008 Modelled IHME
31 (24 - 39) 2007 Modelled IHME
31 (24 - 39) 2006 Modelled IHME
31 (23 - 38) 2005 Modelled IHME
31 (23 - 38) 2004 Modelled IHME
30 (23 - 38) 2003 Modelled IHME
30 (22 - 37) 2002 Modelled IHME
30 (22 - 38) 2001 Modelled IHME
29 (22 - 37) 2000 Modelled IHME
29 (22 - 37) 1999 Modelled IHME
29 (21 - 37) 1998 Modelled IHME
29 (21 - 37) 1997 Modelled IHME
29 (21 - 37) 1996 Modelled IHME
29 (20 - 37) 1995 Modelled IHME
28 (20 - 37) 1994 Modelled IHME
28 (20 - 37) 1993 Modelled IHME
28 (20 - 37) 1992 Modelled IHME
28 (20 - 37) 1991 Modelled IHME
28 (20 - 37) 1990 Modelled IHME
Showing out of
Show more
Technical notes
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Year of birth dose introduction
2003
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
Few (1-10%)

Overview

HBV elimination goal
HCV elimination goal

Hepatitis related deaths (national)

Modelled

HBV
2,446
2019
(1,770 - 3,267)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
2,976
2019
(2,173 - 3,915)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence PWID

No data available

Birth dose vaccination coverage (national)

Survey/surveillance

HBV
73 (%)
2018
WHO/UNICEF

No. of syringes/PWID/year

Survey/surveillance

No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines